BioMarin Pharmaceutical Inc.

BMRN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2009
Assets
Cash & Equivalents $167.2M
Accounts Receivable $73.5M
Inventory $78.7M
Total Current Assets $467.7M
Property, Plant & Equipment $199.1M
Goodwill $23.7M
Intangible Assets (Excl. Goodwill) $41.0M
Total Assets $917.2M
Liabilities
Accounts Payable —
Total Current Liabilities $78.2M
Long-Term Debt —
Total Liabilities $595.0M
Stockholders' Equity
Retained Earnings $-577.1M
Total Stockholders' Equity $322.2M
← Newer Page 3 of 3 Older →